Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994.[A178975] It can effectively manage acute pain as well as pain related to rheumatic diseases, and has a well studied adverse effect profile.[A179098] Given its overall tolerability and effectiveness, naproxen can be considered a first line treatment for a variety of clinical situations requiring analgesia.[A179098] Naproxen is available in both immediate and delayed release formulations, in combination with sumatriptan to treat migraines, and in combination with esomeprazole to lower the risk of developing gastric ulcers.[L6582][L6583][L7309][L7312]
Naproxen Sodium and Pseudoephedrine Hydrochloride Cold and Sinus
Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Headache
Trepoxen-250
Naproxen Sodium Diphenhydramine HCL
Good Neighbor Pharmacy naproxen sodium
Teva-naproxen EC
Naproxen Headache Pain
Up and Up Naproxen Sodium
Riva-naproxen
Naproxen All day relief for pain
Apo-naproxen SR Tablets 750mg
Naproxen Sodium Headache Pain Caplets
Motrimax 12 Hour
Nu-napro-NA
Calmadol Pain Reliever
All Day Relief
Novo-naprox Tab 125mg
Good Sense Naproxen Sodium
Naproxen PM
Naprosyn 375mg Tablets
Mylan-naproxen EC
Signature Care Naproxen Sodium PM
Ntp-naproxen EC
PREVACID NapraPAC 250
Indication
Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682